Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-088355
Filing Date
2024-08-12
Accepted
2024-08-12 16:15:58
Documents
4
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2421402d1_10ka.htm 10-K/A 65362
2 EXHIBIT 4.5 tm2421402d1_ex4-5.htm EX-4.5 39212
3 EXHIBIT 21.1 tm2421402d1_ex21-1.htm EX-21.1 2329
4 EXHIBIT 31.1 tm2421402d1_ex31-1.htm EX-31.1 4788
  Complete submission text file 0001104659-24-088355.txt   112851
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40021 | Film No.: 241197008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)